Patents by Inventor Antoine A. Touzé

Antoine A. Touzé has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY
    Publication number: 20230405140
    Abstract: The invention relates to antibody-drug conjugates and to their use in therapy, in particular for treating CD56+ cancers.
    Type: Application
    Filed: June 12, 2023
    Publication date: December 21, 2023
    Inventors: Ludovic JUEN, Christine BALTUS, Audrey DESGRANGES, Antoine TOUZÉ, Thibault KERVARREC, Valérie LEBLOND, Mahtab SAMIMI
  • ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY
    Publication number: 20230144142
    Abstract: The invention relates to antibody-drug conjugates and to their use in therapy, in particular for treating CD56+ cancers.
    Type: Application
    Filed: February 26, 2021
    Publication date: May 11, 2023
    Inventors: Ludovic JUEN, Christine BALTUS, Audrey DESGRANGES, Antoine TOUZÉ, Thibault KERVARREC, Valérie LEBLOND, Mahtab SAMIMI
  • NEW ANTIBODY TARGETING THE VP-1 PROTEIN, FRAGMENTS THEREOF, AND USES OF SAME FOR DETECTING INFECTION WITH THE BK POLYOMAVIRUS
    Publication number: 20220396612
    Abstract: A new monoclonal antibody targeting the VP-1 protein of the capsid of the BK polyomavirus, fragments thereof, and uses of same for detecting infection with the BK polyomavirus. The monoclonal antibody is capable of recognizing at least all serotypes Ia, Ib2, II, III and IV of the VP-1 protein of the BK polyomavirus.
    Type: Application
    Filed: June 2, 2020
    Publication date: December 15, 2022
    Applicants: UNIVERSITÉ DE TOURS, UNIVERSITE DE PICARDIE JULES VERNE, CENTRE HOSPITALIER UNIVERSITAIRE AMIENS-PICARDIE
    Inventors: Antoine TOUZE, Pauline GABORIAUD, Etienne BROCHOT
  • HPV PARTICLES AND USES THEREOF
    Publication number: 20190142925
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Application
    Filed: November 29, 2018
    Publication date: May 16, 2019
    Applicants: INSERM (Institut National de la Santé et de la Recherche Médicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J.J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • HPV particles and uses thereof
    Patent number: 10179168
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: January 15, 2019
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale, Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J. J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • HPV PARTICLES AND USES THEREOF
    Publication number: 20170368162
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Application
    Filed: June 28, 2017
    Publication date: December 28, 2017
    Applicants: INSERM (Institut National de la Sante et de la Recherche Medicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touze, Maxime J.J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • HPV particles and uses thereof
    Patent number: 9724404
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: August 8, 2017
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Aura Biosciences, Inc.
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J. J. Fleury, Nicolas Combelas, Elisabet de los Pinos
  • HPV PARTICLES AND USES THEREOF
    Publication number: 20120171290
    Abstract: The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.
    Type: Application
    Filed: July 24, 2009
    Publication date: July 5, 2012
    Inventors: Pierre L. Coursaget, Antoine A. Touzé, Maxime J.J. Fleury, Nicolas Combelas, Elisabet de los Pinos